Acrivon Therapeutics Inc (ACRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACRV | CSBR | GANX | ||
| Company | Acrivon Therapeutics Inc | Champions Oncolog | Gain Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.87 | 5.97 | 1.8400 | ||
| High | 2.09 | 6.00 | 1.9250 | ||
| Low | 1.86 | 5.90 | 1.8300 | ||
| Latest | 2.09 | 5.99 | 1.8800 | ||
| Change | +0.24 | +0.03 | -0.0100 | ||
| % Change | +12.97% | +0.50% | -0.53% | ||
| Volume | 867,300 | 6,600 | 424,100 | ||
| 20-Day Average Volume | 879,515 | 7,095 | 558,270 | ||
| Previous Close | 1.85 | 5.96 | 1.8900 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.75 | 5.94 | 1.9335 | ||
| 20-Day Raw Stochastic | 100.00% | 48.37% | 34.73% | ||
| 20-Day Relative Strength | 63.10 | 50.13 | 45.66 | ||
| Weighted Alpha | +64.52 | -0.57 | -26.08 | ||
| Today's Opinion | 24% Buy | 40% Sell | 88% Sell | ||
| Previous Opinion | 8% Sell | 40% Sell | 88% Sell | ||
| Last Month's Opinion | 88% Sell | 88% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.42% since 04/24/26 | +2.13% since 04/24/26 | -4.57% since 04/24/26 | ||
| Low | 1.78 on 04/29/26 | 5.70 on 04/28/26 | 1.7100 on 04/29/26 | ||
| High | 2.09 on 05/01/26 | 6.32 on 04/28/26 | 2.0200 on 04/27/26 | ||
| 1-Month | |||||
| %Chg | +43.15% since 04/01/26 | +1.27% since 04/01/26 | -3.09% since 04/01/26 | ||
| Low | 1.36 on 04/02/26 | 5.65 on 04/02/26 | 1.7100 on 04/29/26 | ||
| High | 2.09 on 05/01/26 | 6.32 on 04/28/26 | 2.1995 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | +16.76% since 01/30/26 | -18.06% since 01/30/26 | +4.44% since 01/30/26 | ||
| Low | 1.27 on 03/30/26 | 5.50 on 03/13/26 | 1.6100 on 02/05/26 | ||
| High | 2.09 on 05/01/26 | 7.23 on 02/02/26 | 3.0699 on 03/06/26 | ||
| 6-Month | |||||
| %Chg | +5.03% since 10/31/25 | -12.43% since 10/31/25 | -4.08% since 10/31/25 | ||
| Low | 1.27 on 03/30/26 | 5.50 on 03/13/26 | 1.6100 on 02/05/26 | ||
| High | 3.56 on 01/07/26 | 8.31 on 12/15/25 | 4.3400 on 12/11/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 80,975 | 83,183 | 80,190 | ||
| Shares Outstanding, K | 38,744 | 13,887 | 42,654 | ||
| Annual Sales | 0 | 56,940,000 | 0 | ||
| Annual Net Income | -77,910,000 | 4,700,000 | -20,160,000 | ||
| Last Quarter Sales | 0 | 16,560,000 | 0 | ||
| Last Quarter Net Income | -18,990,000 | -280,000 | -4,540,000 | ||
| 60-Month Beta | 2.01 | 0.43 | 0.15 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 03/19/26 | -0.02 on 03/12/26 | -0.11 on 03/26/26 | ||
| Earnings Date | 05/13/26 | 07/22/26 | 05/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||